Athens Medical Center S.A.

At Athens Medical Center S.A., research in cardiovascular diseases focuses on conditions such as atherosclerotic cardiovascular disease, hypertension, and elevated Lp(a), with added attention to chronic kidney disease and overall heart-kidney risk. The trials are aimed at testing new therapies and assessing whether they can reduce major cardiovascular events, protect kidney function, and improve long-term outcomes.

• Studies in atherosclerotic cardiovascular disease and elevated Lp(a)
• Trials for hypertension linked to obesity and diabetes
• Research on chronic kidney disease and prevention of worsening kidney outcomes

These studies reflect a strong interest in treatments that may lower the risk of heart attacks, stroke, and related complications while supporting better chronic disease control.

The Department of Internal Medicine & Diabetes is actively involved in trials for type 2 diabetes, obesity, and overweight, often alongside related metabolic conditions. The research is centered on improving blood sugar control, supporting weight loss, and evaluating whether newer therapies can also reduce cardiovascular risk.

• Trials in type 2 diabetes focused on glucose control and treatment effectiveness
• Studies in obesity and overweight examining weight reduction and related health benefits
• Research connecting metabolic treatment with cardiovascular disease prevention

Several projects also look at broader metabolic health, including how treatment may affect long-term complications in people living with diabetes or excess body weight.

Clinical research at the site includes a substantial neoplasms portfolio, with studies in colorectal cancer, gastric cancer, gastroesophageal junction cancer, esophageal cancer, non-small cell lung cancer, and pancreatic cancer. These trials are mainly designed to evaluate new treatment combinations and compare their effectiveness against current standard approaches.

• Studies in colorectal cancer, including metastatic and biomarker-defined disease
• Trials for gastric and gastroesophageal junction cancers
• Research in non-small cell lung cancer and pancreatic ductal adenocarcinoma

This oncology work emphasizes improving survival, delaying disease progression, and identifying better options for patients with advanced or difficult-to-treat cancers.

In skin and connective tissue diseases, the site is studying cutaneous lupus erythematosus and hidradenitis suppurativa. The purpose of these trials is to assess new treatment options that may reduce symptoms, improve skin manifestations, and offer better disease control for patients with chronic inflammatory conditions.

• Trials in cutaneous lupus erythematosus targeting skin improvement
• Studies in hidradenitis suppurativa focused on symptom relief and response rates
• Research on immune-driven skin disease with an emphasis on treatment effectiveness

These investigations support a growing interest in therapies for persistent dermatologic diseases that can strongly affect quality of life.

The trial portfolio at Athens Medical Center S.A. also brings together nutritional and metabolic diseases with cardiovascular research, reflecting the close link between metabolism, heart health, and weight-related illness. The studies are intended to test whether emerging therapies can improve multiple health outcomes at once, including blood sugar, body weight, blood pressure, and cardiovascular risk.

• Integrated studies in type 2 diabetes and hypertension
• Research in overweight and obesity with attention to cardiometabolic benefit
• Trials evaluating whether new treatments can improve several related chronic conditions together

This broad research focus highlights the site’s role in studying diseases that often occur together and require coordinated long-term care.